Clinical Trial Update: CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of CT-322 in patients with advanced solid tumors and non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• CT-322

Snippet

Sponsor: Adnexus, A Bristol-Myers Squibb R&D Company | Conditions: Cancer | Phase 1 | Status: COMPLETED